We investigated and confirmed this hypothesis in the present study, at least for HBD-1: The previously postulated constitutive expression of HBD-1 in the gastrointestinal tract appears to be modulated by the metabolic state, and reduced expression might contribute towards impaired mucosal barrier function in diabetes. This evidence concerns the gene DEFB1 and diabetes mellitus.